Post-approval studies (Phase 4)Study completedNCT01272362
What this trial is testing
To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol
Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 625